污水處理設備 污泥處理設備 水處理過濾器 軟化水設備/除鹽設備 純凈水設備 消毒設備|加藥設備 供水/儲水/集水/排水/輔助 水處理膜 過濾器濾芯 水處理濾料 水處理劑 水處理填料 其它水處理設備
廈門慧嘉生物科技有限公司
暫無信息 |
閱讀:316發布時間:2013-5-16
Human Aldosterone(ALD)
ELISA Kit
Catalog No. CSB-E07026h
(96 tests)
This immunoassay kit allows for the in vitro rapid detection of human ALD
concentrations in serum, plasma and other biological fluids.
Expiration date six months from the date of manufacture
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.
2
INTRODUCTION
Aldosterone is a hormone that increases the reabsorption of
sodium and water and the release (secretion) of potassium in the
kidneys. This increases blood volume and, therefore, increases
blood pressure. Drugs that interfere with the secretion or action
of aldosterone are in use as antihypertensives. One example is
spironolactone, which lowers blood pressure by blocking the
aldosterone receptor. Aldosterone is part of the
renin-angiotensin system. A measurement of aldosterone in
blood may be termed a plasma aldosterone concentration (PAC),
which may be compared to plasma renin activity (PRA) as a
PAC/PRA ratio.
Aldosterone is a steroid hormone (mineralocorticoid family)
produced by the outer-section (zona glomerulosa) of the adrenal
cortex in the adrenal gland, and acts on the distal tubules and
collecting ducts of the nephron, the functioning unit of the kidney
to cause the conservation of sodium, secretion of potassium,
increased water retention, and increased blood pressure. The
overall effect of aldosterone is to increase reabsorption of ions
and water in the kidney.
Its activity is reduced in Addison's disease and increased in
Conn syndrome.
3
PRINCIPLE OF THE ASSAY
This assay employs the competitive inhibition enzyme
immunoassay technique. An antibody specific to ALD has been
pre-coated onto a microplate. Standards or samples are added
to the appropriate microtiter plate wells with HRP-conjugated
ALD and incubated. A competitive inhibition reaction is launched
between ALD (Standards or samples) and HRP-conjugated ALD
with the pre-coated antibody specific for ALD. The more amount
of ALD in samples, the less antibody bound by HRP-conjugated
ALD. Then the substrate solutions are added to the wells,
respectively. And the color develops in opposite to the amount of
ALD in the sample. The color development is stopped and the
intensity of the color is measured.
DETECTION RANGE
The standard curve concentrations used for the ELISA’s were
1000pg/ml, 266.6 pg/ml, 66.6 pg/ml, 26.6 pg/ml, 13.3pg/ml.
SPECIFICITY
This assay recognizes human ALD. No significant
cross-reactivity or interference was observed.
4
SENSITIVITY
The minimum detectable dose of human ALD is typically less
than 0.66 pg/ml.
The sensitivity of this assay, or Lower Limit of Detection (LLD)
was defined as the lowest protein concentration that could be
differentiated from zero.
MATERIALS PROVIDED
Reagent Quantity
Assay plate 1
Standards (S1-S5) 5
HRP-conjugate 1 x 6 ml
Wash Buffer
1 x 15 ml
(20×concentrate)
Substrate A 1 x 6 ml
Substrate B 1 x 6 ml
Stop Solution 1 x 6 ml
Standard S1 S2 S3 S4 S5
Concentration
(pg/ml)
13.3 26.6 66.6 266.6 1000
5
STORAGE
1. Unopened test kits should be stored at 2-8°C upon receipt
and the microtiter plate should be kept in a sealed bag. The
test kit may be used throughout the expiration date of the kit,
provided it is stored as prescribed above. Refer to the
package label for the expiration date.
2. Opened test plate should be stored at 2-8°C in the aluminum
foil bag with desiccants to minimize exposure to damp air. The
kits will remain stable until the expiring date shown, provided it
is stored as prescribed above.
3. A microtiter plate reader with a bandwidth of 10 nm or less
and an optical density range of 0-3 OD or greater at 450nm
wavelength is acceptable for use in absorbance
measurement.
TECHNICAL HINTS
1. Bring all reagents and plate to room temperature for at least
30 minutes before use. Unused wells need store at 2-8℃and
avoid sunlight.
2. Wash Buffer If crystals have formed in the concentrate,
warm to room temperature and mix gently until the crystals
6
have compley dissolved. Dilute 15 ml of Wash Buffer
Concentrate into deionized or distilled water to prepare 300 ml
of Wash Buffer.
3. To avoid cross-contamination, change pipette tips between
additions of each standard level, between sample additions,
and between reagent additions. Also, use separate reservoirs
for each reagent.
4. When using an automated plate washer, adding a 30 second
soak period following the addition of wash buffer, and/or
rotating the plate 180 degrees between wash steps may
improve assay precision.
5. Substrate Solution should remain colorless or light blue until
added to the plate. Keep Substrate Solution protected from
light. Substrate Solution should change from colorless or light
blue to gradations of blue.
6. Stop Solution should be added to the plate in the same order
as the Substrate Solution. The color developed in the wells
will turn from blue to yellow upon addition of the Stop Solution.
Wells that are green in color indicate that the Stop Solution
has not mixed thoroughly with the Substrate Solution.
Precaution: The Stop Solution provided with this kit is an acid solution. Wear
eye, hand, face, and clothing protection when using this material.
7
OTHER SUPPLIES REQUIRED
Microplate reader capable of measuring absorbance at 450
nm, with the correction wavelength set at 540 nm or 570 nm.
Pipettes and pipette tips.
Deionized or distilled water.
Squirt bottle, manifold dispenser, or automated microplate
washer.
An incubator which can provide stable incubation conditions
up to 37°C±0.5°C.
SAMPLE COLLECTION AND STORAGE
Serum Use a serum separator tube (SST) and allow
samples to clot for 30 minutes before centrifugation for 15
minutes at 1000 x g. Remove serum and assay immediay
or aliquot and store samples at -20°C. Centrifuge t he sample
again after thawing before the assay. Avoid repeated
freeze-thaw cycles.
Plasma Collect plasma using citrate, EDTA, or heparin as
an anticoagulant. Centrifuge for 15 minutes at 1000 x g within
30 minutes of collection. Assay immediay or aliquot and
store samples at -20°C. Centrifuge the sample again after
thawing before the assay. Avoid repeated freeze-thaw cycles.
Note: Grossly hemolyzed samples are not suitable for use in this assay.
8
ASSAY PROCEDURE
Bring all reagents and samples to room temperature before use. It is
recommended that all samples, standards, and controls be assayed in duplicate.
All the reagents should be added directly to the liquid level in the well. The
pipette should avoid contacting the inner wall of the well.
1. Set a Blank well without any solution. Add 50µl of Standard
or Sample per well. Standard need test in duplicate.
2. Add 50µl of HRP-conjugate to each well (not to Blank well),
Mix well and then incubate for 1 hour at 37°C.
3. Fill each well with Wash Buffer (about 200µl), stay for 10
seconds and Spinning. Repeat the process for a total of
three washes. Complete removal of liquid at each step is
essential to good performance. After the last wash, remove
any remaining Wash Buffer by aspirating or decanting.
Invert the plate and blot it against clean paper towels.
4. Add 50µl of Substrate A and Substrate B to each well, mix
well. Incubate for 15 minutes at 37°C. Keeping the plate
away from drafts and other temperature fluctuations in the
dark.
5. Add 50µl of Stop Solution to each well when the first four
wells containing the highest concentration of standards
develop obvious blue color. If color change does not appear
uniform, gently tap the plate to ensure thorough mixing.
9
6. Determine the optical density of each well within 10 minutes,
using a microplate reader set to 450 nm.
CALCULATION OF RESULTS
Using the professional soft "Curve Exert 1.3" to make a standard curve is
recommended, which can be downloaded from our web.
Average the duplicate readings for each standard, Blank, and
sample and subtract the optical density of Blank. Create a
standard curve by reducing the data using computer software
capable of generating a four parameter logistic (4-PL) curve-fit.
As an alternative, construct a standard curve by plotting the
mean absorbance for each standard on the y-axis against the
concentration on the x-axis and draw a best fit curve through the
points on the graph. The data may be linearized by plotting the
log of the ALD concentrations versus the log of the O.D. and the
best fit line can be determined by regression analysis. This
procedure will produce an adequate but less precise fit of the
data. If samples have been diluted, the concentration read from
the standard curve must be multiplied by the dilution factor.
LIMITATIONS OF THE PROCEDURE
The kit should not be used beyond the expiration date on the
kit label.
10
Do not mix or substitute reagents with those from other lots or
sources.
If samples generate values higher than the highest standard,
dilute the samples with the appropriate Diluent and repeat the
assay.
Any variation in operator, pipetting technique, washing
technique, incubation time or temperature, and kit age can
cause variation in binding.
This assay is designed to eliminate interference by soluble
receptors, binding proteins, and other factors present in
biological samples. Until all factors have been tested in the
Quantikine Immunoassay, the possibility of interference
cannot be excluded.
環保在線 設計制作,未經允許翻錄必究 .? ? ?
請輸入賬號
請輸入密碼
請輸驗證碼
請輸入你感興趣的產品
請簡單描述您的需求
請選擇省份